US1881197A - Medical tablet - Google Patents
Medical tablet Download PDFInfo
- Publication number
- US1881197A US1881197A US412094A US41209429A US1881197A US 1881197 A US1881197 A US 1881197A US 412094 A US412094 A US 412094A US 41209429 A US41209429 A US 41209429A US 1881197 A US1881197 A US 1881197A
- Authority
- US
- United States
- Prior art keywords
- tablet
- coating
- stomachic
- stomach
- enteric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Definitions
- This invention relates to a medical tablet, and more particularly medical tablets of the type having an enteric coating.
- enteric covered tablets containing an intestinal disinfectant or other medication have been provided, the coating being soluble only in an alkaline medium, whereby the coating is not attacked by the acids of the stomach, and the tablet not dissolved until it comes into contact with the alkaline fluids in the intestines. It has frequently been found, however, that atthe time the tablet is taken, the contents of the stomach may not be of proper acidity, and under certain cir- 35cumstances may be definitely alkaline. Inv this case the enteric coating is prematurely dissolved.
- a tablet having a second coating external to the enteric coating" containing some stomachic which will definitely stimulate the secretion of hydrochloric acid in the stomach, preventing premature solution of the enteric coating.
- the medicant 2 is protected by a shield 3 commonly referred to in the art as an enteric coating, and which is H soluble 8nly in an alkaline medium.
- a shield 3 commonly referred to in the art as an enteric coating, and which is H soluble 8nly in an alkaline medium.
- Applied to the surface of the enteric coating 3 is another coating 4 of a stomachic,- such for instance as ginger, clove, cinnamon, or any similar substance intended to stimulate the I secretion of hydrochloric acid in the stomach.
- the stomachic 4 When the tablet is taken, the stomachic 4 is immediately dissolved or difiused throu h the contents of the stomach, stimulating the secretion of hydrochloric acid. The contents are. therefore. made definitelv acid during the time the tablet remains in the stomach.
- the external coating When the tablet passes into the intestine, the external coating has been removed and the. enteric shield 3 may be dissolved in the alkaline fluids of the intestines.
- the stomachic may be combined with a sugar coating, or the tablet may be further provided with a sugar coating 5 outside the coating of stomachic. This is disclosed in Figure 2, wherein the tablet is the same as that shown in Fi re 1 with the exception that the additional envelope 5 is provided.
- the invention by the simple provision of the stomachic, secures an enteric-coated tablet which will always provide conditions in the stomach adverse to the dissolution of the enteric coating, and thus revent premature release of the contents of the tablet.
- an enteric- .covered tablet the enteric coating of which is soluble only in an alkaline medium, and an enclosing la er external to the enteric coating comprising a stomachic ada ted to stimulate the secretion of hydrochloric acid in the stomach.
Description
001. 4, 932. I KmK 1,881,197
MEDICAL TABLET Filed Dec. 6, 1929 of the stom'ac Patented Oct. 4, 1932 UNITED STATES.
WILLIAM J. KIRK, OI wmsam, WEST VIRGINIA mmrcn. TABLE! Application fled December 6, ma. Serial 10.412.004.
This invention relates to a medical tablet, and more particularly medical tablets of the type having an enteric coating.
Heretofore enteric covered tablets containing an intestinal disinfectant or other medication have been provided, the coating being soluble only in an alkaline medium, whereby the coating is not attacked by the acids of the stomach, and the tablet not dissolved until it comes into contact with the alkaline fluids in the intestines. It has frequently been found, however, that atthe time the tablet is taken, the contents of the stomach may not be of proper acidity, and under certain cir- 35cumstances may be definitely alkaline. Inv this case the enteric coating is prematurely dissolved. Accordin to the present invention, there is provide a tablet having a second coating external to the enteric coating" containing some stomachic which will definitely stimulate the secretion of hydrochloric acid in the stomach, preventing premature solution of the enteric coating. I
The invention may be readily understood by reference to the accompanying drawing,
effective in the intestine. The medicant 2 is protected by a shield 3 commonly referred to in the art as an enteric coating, and which is H soluble 8nly in an alkaline medium. Applied to the surface of the enteric coating 3 is another coating 4 of a stomachic,- such for instance as ginger, clove, cinnamon, or any similar substance intended to stimulate the I secretion of hydrochloric acid in the stomach.
When the tablet is taken, the stomachic 4 is immediately dissolved or difiused throu h the contents of the stomach, stimulating the secretion of hydrochloric acid. The contents are. therefore. made definitelv acid during the time the tablet remains in the stomach. When the tablet passes into the intestine, the external coating has been removed and the. enteric shield 3 may be dissolved in the alkaline fluids of the intestines.
In order to make the tablet more palatable and protect the stomachic, the stomachic may be combined with a sugar coating, or the tablet may be further provided with a sugar coating 5 outside the coating of stomachic. This is disclosed in Figure 2, wherein the tablet is the same as that shown in Fi re 1 with the exception that the additional envelope 5 is provided.
The invention, by the simple provision of the stomachic, secures an enteric-coated tablet which will always provide conditions in the stomach adverse to the dissolution of the enteric coating, and thus revent premature release of the contents of the tablet.
While I have referred to the contents of the tablet as bein of a specific nature, it will be understood t at the invention is not confined to the use of any particular material within the tablet, but is applicable to any tablet wherein it is desirable to employ an enteric coating soluble only under an alkaline medium. I- have also referred to gin er as a s cific stomachic, but it will be un erstood t at any one of a large number of substances intended to stimulate the secretion of h drochloric acid in the stomach may be use I claim:
As an article of manufacture, an enteric- .covered tablet, the enteric coating of which is soluble only in an alkaline medium, and an enclosing la er external to the enteric coating comprising a stomachic ada ted to stimulate the secretion of hydrochloric acid in the stomach.
In testimony whereof I have hereunto set my hand. J K
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US412094A US1881197A (en) | 1929-12-06 | 1929-12-06 | Medical tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US412094A US1881197A (en) | 1929-12-06 | 1929-12-06 | Medical tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
US1881197A true US1881197A (en) | 1932-10-04 |
Family
ID=23631581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US412094A Expired - Lifetime US1881197A (en) | 1929-12-06 | 1929-12-06 | Medical tablet |
Country Status (1)
Country | Link |
---|---|
US (1) | US1881197A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2757124A (en) * | 1952-03-08 | 1956-07-31 | Merck & Co Inc | Tablets and method of producing same |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US5200197A (en) * | 1989-11-16 | 1993-04-06 | Alza Corporation | Contraceptive pill |
-
1929
- 1929-12-06 US US412094A patent/US1881197A/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2757124A (en) * | 1952-03-08 | 1956-07-31 | Merck & Co Inc | Tablets and method of producing same |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US5200197A (en) * | 1989-11-16 | 1993-04-06 | Alza Corporation | Contraceptive pill |
US5842476A (en) * | 1989-11-16 | 1998-12-01 | Alza Corporation | Method for controlling fertility |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2099402A (en) | Pill or tablet | |
US1881197A (en) | Medical tablet | |
Zollinger et al. | Ulcerogenic tumors of the pancreas | |
Antoniades et al. | Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives | |
US1815902A (en) | Device for administering medicaments | |
Alford et al. | IX Chemical Burns of the Mouth, Pharynx and Esophagus | |
US2033495A (en) | Anthelmintic | |
US3364111A (en) | Carboxymethylated dextran for peptic ulcers | |
US2333283A (en) | Administration capsule | |
US2455790A (en) | Enteric coatings | |
US2071511A (en) | Enteric coating | |
US2481804A (en) | Penicillin-pectin composition and method of manufacture | |
US3155575A (en) | Composition for inhibiting pepsin activity and method of preparing same | |
Hadley et al. | Epidermolysis bullosa | |
US2333950A (en) | Therapeutic pectous product | |
US1907203A (en) | Coating for tablets, capsules, and pills | |
US1683466A (en) | Capsule | |
US2775538A (en) | Stabilized hexylresorcinol therapeutic agent containing castor oil | |
US3193457A (en) | Oral administration of 6, 16alpha-dimethyl-progesterones | |
US1746984A (en) | Vehicle for acetyl-salicylic acid tablets | |
Manville et al. | Studies on the gastric hunger mechanism: II. The inhibitory effect of dextrose solutions | |
Connell | SURGICAL TREATMENT OF DUODENAL ULCER | |
Mehrotra et al. | Contraceptive pills and acute pancreatitis | |
US1969998A (en) | Combination of salicylic acid and calcium salts | |
ABRAMOWITZ et al. | Fixed eruption from magnesium hydroxide: Polysensitivity |